Author

D. N. Wald

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Approach:deep learning· 2 Assay:proteomics· 2 Research Focus:cell-cell communication· 1 Assay:ChIP-seq· 1 Assay:CRISPR screen· 1

Frequent Co-Authors

A. R. Morton· 1 shared A. Saiakhova· 1 shared B. Dropulic· 1 shared B. G. LUTTGE· 1 shared C. Dobrowolski· 1 shared C. F. Bartels· 1 shared C. Hong· 1 shared D. McMahon· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. R. Morton

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Reduction of the HIV-1 reservoir in T cells from persons with HIV-1 on suppressive antiretroviral therapy using expanded natural killer cells ex vivo

M. A. Checkley Luttge, B. G. LUTTGE, C. Dobrowolski, D. N. Wald, D. McMahon, G. Haidar, M. D. Sobolewski, P. N. Enick, J. Cyktor, J. W. Mellors, J. Karn

This study shows that expanded natural killer cells can reduce HIV-1 reservoirs in treated patients when combined with latency-reversing agents and broadly neutralizing antibodies.

bioRxiv · Sep 5, 2022 · PreprintImmunology

Sequential single cell transcriptional and protein marker profiling reveals TIGIT as a marker of CD19 CAR-T cell dysfunction in patients with non-Hodgkin lymphoma

Z. G. Jackson, C. Hong, R. Schauner, B. Dropulic, P. F. Caimi, M. de Lima, K. Gupta, J. S. Reese, T. H. Hwang, D. N. Wald

The paper identifies TIGIT as a marker of CD19 CAR-T cell dysfunction in NHL patients through single-cell transcriptional and protein profiling.

bioRxiv · Apr 26, 2021Immunology

Mismatch-repair signature mutations activate gene enhancers across colorectal cancer epigenomes

S. Hung, A. Saiakhova, Z. Faber, C. F. Bartels, D. Neu, I. Bayles, E. Ojo, E. S. Hong, W. D. Pontius, A. R. Morton, R. Liu, M. F. Kalady, D. N. Wald, S. Markowitz, P. C. Scacheri

The paper identifies MMR signature mutations in colorectal cancer that activate enhancers by increasing FOX factor affinity and promoting tumor growth.

bioRxiv · Sep 7, 2018Cancer Biology